XORTX Therapeutics Inc. Transfers Of Research And Development To Entity Related Party Transactions
XORTX Therapeutics Inc. (XRTX) reported Transfers Of Research And Development To Entity Related Party Transactions of CAD 106.37 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Notes
ifrs-full:TransfersOfResearchAndDevelopmentToEntityRelatedPartyTransactions · last filed 2022-05-03
| Period end | Transfers Of Research And Development To Entity Related Party Transactions 12 month |
|---|---|
| 2021-12-31 | 106.37K CAD 20-F · filed 2022-05-03 |